https://www.selleckchem.com/pr....oducts/cetuximab.htm
oviding a novel therapy for myocardial repair following MI. Our results demonstrate that a DP scaffold contains multiple growth and angiogenic factors that enhance the maturation and survival of seeded hiPSC-CMs. Transplantation of a BCP is superior to DP or hiPSC-CMs alone in reducing infarct size and improving cell retention and neovascularization, thus providing a novel therapy for myocardial repair following MI.The progress in our understanding of the endogenous protein concept over the past century is reviewed. Non-dietary protei
Me gusta
Comentario
Compartir
